肺癌切除术后再插管:预测评分的开发与外部验证
该研究基于2所大学医院2008至2020年2672例肺癌切除术患者(开发队列1754例,验证队列918例),开发并外部验证了PROREAL评分以预测术后7天内再插管(共71例,2.7%)。评分在开发队列ROC AUC为0.90(95% CI 0.87-0.94),验证队列为0.74(95% CI 0.66-0.82),均优于SPORC评分。
要点
- PROREAL评分包含手术范围与入路、ASA分级、心力衰竭、肾脏疾病和DLCO等变量。
- 评分在开发队列区分度优秀(AUC 0.90),验证队列良好(AUC 0.74)。
- 评分≥5在开发队列敏感度88%、特异度81%。
核心结论
- PROREAL评分能较非特异性SPORC评分更准确地预测肺癌术后再插管,可能识别出高危手术候选人以进行预防性干预或替代肿瘤治疗。
研究设计与样本
- 研究分析了2所大学医院的肺癌切除术病例,开发队列1754例,验证队列918例,纳入时间为2008年至2020年。
- 主要终点为术后7天内再插管,预测因子通过后退逐步logistic回归和bootstrap重采样筛选。
主要发现
- 共2672例患者中71例(2.7%)在术后7天内再插管。
- 识别出的评分变量包括手术范围和入路、美国麻醉医师协会(ASA)身体状况分级、心力衰竭、肾脏疾病和一氧化碳弥散量(DLCO)。
- 开发队列ROC AUC为0.90(95% CI 0.87-0.94),验证队列ROC AUC为0.74(95% CI 0.66-0.82)。
- 评分在两个队列中均优于SPORC(开发队列P < .001,验证队列P = .018),验证队列净重分类改善为0.39(95% CI 0.18-0.60;P = .001)。
- 评分 cutoff ≥5 在开发队列的敏感度为88%(95% CI 72-95),特异度为81%(95% CI 79-83)。
关键数值与推荐
- PROREAL评分 cutoff ≥5 在开发队列敏感度88%(95% CI 72-95)、特异度81%(95% CI 79-83)。
- 开发队列ROC AUC 0.90(95% CI 0.87-0.94),验证队列ROC AUC 0.74(95% CI 0.66-0.82)。
临床怎么用
- 作者认为,PROREAL评分可能识别出有风险的手术候选人以进行预防性干预或替代肿瘤治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reintubation after lung cancer resection is an important quality metric because of increased disability, mortality and cost. However, no validated predictive instrument is in use to reduce reintubation after lung resection. This study aimed to create and validate the PRediction Of REintubation After Lung cancer resection (PROREAL) score. METHODS: The study analyzed lung resection cases from 2 university hospitals. The primary end point was reintubation within 7 days after surgery. Predictors were selected through backward stepwise logistic regression and bootstrap resampling. The investigators used reclassification and receiver-operating characteristic (ROC) curve analyses to assess score performance and compare it with an established score for all surgical patients (Score for Prediction of Postoperative Respiratory Complications [SPORC]). RESULTS: The study included 2672 patients who underwent resection for lung cancer (1754, development cohort; 918, validation cohort) between 2008 and 2020, of whom 71 (2.7%) were reintubated within 7 days after surgery. Identified score variables were surgical extent and approach, American Society of Anesthesiologists physical status, heart failure, renal disease, and diffusing capacity of the lung for carbon monoxide. The score achieved excellent discrimination in the development cohort (ROC AUC, 0.90; 95% CI, 0.87-0.94) and good discrimination in the validation cohort (ROC AUC, 0.74, 95% CI; 0.66-0.82), thus outperforming the SPORC in both cohorts (P < .001 and P = .018, respectively; validation cohort net reclassification improvement, 0.39; 95% CI, 0.18-0.60; P = .001). The score cutoff of ≥5 yielded a sensitivity of 88% (95% CI, 72-95) and a specificity of 81% (95% CI,79-83) in the development cohort. CONCLUSIONS: A simple score (PROREAL) specific to lung cancer predicts postoperative reintubation more accurately than the nonspecific SPORC score. Operative candidates at risk may be identified for preventive intervention or alternative oncologic therapy.
引用
- Linhardt FC, Santer P, Xu X, et al. Reintubation After Lung Cancer Resection: Development and External Validation of a Predictive Score. Ann Thorac Surg. 2022. PMID: 35690135. doi:10.1016/j.athoracsur.2022.05.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。